Attachment 114 -- MPC Pharmacy Cover Letter

Attachment 114 -- MPC Pharmacy Cover Letter.doc

Medical Expenditure Panel Survey Household Component and Medical Provider Component (MEPS-HC and MEPS-MPC through 2009)

Attachment 114 -- MPC Pharmacy Cover Letter

OMB: 0935-0118

Document [doc]
Download: doc | pdf



DEPARTMENT OF HEALTH & HUMAN SERVICES Agency for Healthcare

Research and Quality



Dear [FILL PROVIDER NAME]:


We understand that one of our data collection specialists has talked to you about the Medical Provider Component of the Medical Expenditure Panel Survey. We are appreciative of the contributions you and your health care agency are providing to this important study that is being conducted for the Agency for Healthcare Research and Quality (AHRQ) and the Centers for Disease Control and Prevention (CDC), both part of the U.S. Department of Health and Human Services. We wanted to take this opportunity to tell you more about the study.


The objective of the study is to provide accurate information to government policymakers and private researchers about the rapidly changing health care situation in this country. To accomplish this goal, we have collected data from a cross-section of American households on how they used and paid for health care during 2009. With the written permission of members of these households, we are now contacting their pharmacy providers to determine the actual fill dates, NDC, charges, sources of payment and the amount that was paid. One or more of your pharmacy customers has given us written authorization to request this information from your records.


The study materials enclosed with this letter include a list of your pharmacy customers who have agreed to participate in the survey and an authorization form for each patient.


This survey is authorized by section 902(a) of the Public Health Services Act [42 U.S.C. 299a]. Participation is voluntary, but we are depending on you to help us toward a more complete understanding of the nation’s health care. The patient information we obtain will be used for research purposes only and will be released publicly only in summary form in which establishments or individuals cannot be identified. The confidentiality of patient information is protected by Federal Statute, Section 934(c) and Section 308(d) of the Public Health Service Act [42 U.S.C. 299c-3(c) and 242m(d)] and will be kept private to the extent permitted by law. This law prohibits the release outside of the sponsoring agencies or their contractors of information that would permit identification of a patient or establishment without first obtaining authorization from the patient or establishment who gave the information.


The U.S. Department of Health and Human Services has selected a new data collection team to administer the study - RTI International (RTI) and Social and Scientific Systems, Inc. (SSS).


A Data Collection Specialist from RTI-SSS will call shortly after you have received these materials to see if you have any questions and to arrange for the collection of these data. If you have questions about the forms or procedures, call RTI-SSS, toll-free at [FILL NUMBER: 1-800-XXX-XXXX].

Sincerely,

Carolyn M. Clancy, M.D. Edward J. Sondik, Ph.D.

Director Director

Agency for Healthcare National Center for Health Statistics

Research and Quality Centers for Disease Control and Prevention


File Typeapplication/msword
AuthorAnger_d
Last Modified Bywcarroll
File Modified2009-08-12
File Created2009-07-23

© 2024 OMB.report | Privacy Policy